46-60 of 139
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®Bridging ASCVD Care Between Academic and Rural Settings
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CENonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
- advertisement
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®An Overview of Current and Emerging Treatment Options for Hemophilia A & B
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®The Impact of Hemophilia Across Patients’ Lives
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®Evaluating Emerging Treatment Options: Rebalancing Therapies
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
- advertisement
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
MinuteCE®Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment













































